Form D · Biotechnology
INSPIRATION BIOPHARMACEUTICALS INC
Laguna Niguel, CA · CIK 0001428124
Offering snapshot reported Mar 29, 2011 · SEC filing
- Reported sold
- $248M Offering amount: $372M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $435K Reported outside-investor minimum
- First sale
- Oct 30, 2009 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$197,640,946 → $247,640,946
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 29, 2011 | Amendment | $247,640,946 | $50,000,000vs Jan 29, 2010 | 4 | SEC filing |
| Jan 29, 2010 | Amendment | $197,640,946 | $192,640,946vs Nov 13, 2009 | 4 | SEC filing |
| Nov 13, 2009 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Jul 23, 2009 | Initial | $10,984,600 | No comparison | 14 | SEC filing |
| Dec 4, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Feb 21, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Debt, Option to acquire, Security to be acquired
- Exemptions
- 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $5.94M
- Finders' fees
- $0
- Form D file number
- 021-115176
Total Offering includes: 1 new outside equity investment, 2 non-equity exchanged for equity, 3 exchange of previous equity for new series of equity, 4 partial equity commission payment, 5 potential future milestone based notes convertible into equity.
The total value of the Sales Commission includes both cash and equity components.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Healthios, Inc. | None |
Source: Form D, filed Mar 29, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gordon H. Busenbark | Executive |
| Karen Dawes | Director |
| Stephen R. Evans Freke | Director |
| Barry R. Frankel | Director |
| Michael J. Giffith | Director, Executive |
| Andrew Grethlein | Executive |
| Michael J. Griffith | Director, Executive |
| Scott D. Martin | Director, Promoter |
| Gerard Picot | Director |
| Lynne R. Rollins | Executive |
| John R. Taylor | Director, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
28202 Cabot Road Suite 300
Laguna Niguel, CA, 92677
Laguna Niguel, CA, 92677